Suchergebnisse - "Emadi, Ashkan"

PubPharm (6)

1

Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and IDH1 R132C mutation

enthalten in: Leukemia & lymphoma | 2022

von Alkhaldi, H. | Sewell, D. | Ning, Y. | +4

2

Comparative Analysis of Methods for Detecting Isocitrate Dehydrogenase 1 and 2 Mutations and Their Metabolic Consequence, 2-Hydroxyglutarate, in Different Neoplasms

enthalten in: Applied immunohistochemistry & molecular morphology : AIMM | 2017

von Babakoohi, S. | Lapidus, R. | Faramand, R. | +2

3

Biochemical, Epigenetic, and Metabolic Approaches to Target IDH Mutations in Acute Myeloid Leukemia

enthalten in: Seminars in hematology | 2015

von Fathi, A. | Wander, S. | Faramand, R. | +1

4

Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia

enthalten in: American journal of hematology | 2015

von Emadi, A. | Faramand, R. | Carter-Cooper, B. | +7

5

Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations

enthalten in: Experimental hematology | 2014

von Emadi, A. | Jun, S. | Tsukamoto, T. | +3

6

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

enthalten in: Blood | 2012

von Fathi, A. | Sadrzadeh, H. | Borger, D. | +18

1
[1]